Skip to main content Accessibility help
×
Home
  • Print publication year: 2010
  • Online publication date: November 2010

Part II - Hypersomnias of central origin

Suggested reading

AASM (American Academy of Sleep Medicine). International Classification of Sleep Disorders, 2nd edn.: Diagnostic and Coding Manual. Westchester, Illinois: American Academy of Sleep Medicine, 2005.
HungsM, MignotE. Hypocretin/orexin, sleep and narcolepsy. Bioessays 2001; 23: 397–408.
LuJ, ShermanD, DevorM, et al. A putative flip–flop switch for control of REM sleep. Nature 2006; 441: 589–94.
MorgenthalerTI, KapurVK, BrownT, et al. Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep 2007; 30: 1705–11.
NevsimalovaS. Narcolepsy in childhood. Sleep Med Rev 2009; 13: 169–80.

Suggested reading

Historical
PassouantP.The history of narcolepsy. In: GuilleminaultC, DementWC, PassouantP, eds. Narcolepsy. New York: Spectrum, 1976; 3–14.
WilsonS.The narcolepsies. Brain 1928; 51: 63–77.
Review
BaumannCR, BassettiCL.Hypocretins (orexins) and sleep-wake disorders. Lancet Neurol 2005; 4: 673–82.
General
AASM (American Academy of Sleep Medicine). International Classification of Sleep Disorders, 2nd edn.: Diagnostic and Coding Manual. Westchester, Illinois: American Academy of Sleep Medicine, 2005.
LittnerMR, KushidaC, WiseM, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005; 28: 113–21.
MignotE, LammersGJ, RipleyB, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002; 59: 1553–62.
MorgenthalerTI, KapurVK, BrownT, et al. Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep 2007; 30: 1705–11.
SilberMH, RyeDB.Solving the mystery of narcolepsy. The hypocretin story. Neurology 2001; 56: 1616–18.
WeaverTE, CuéllarN.A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy. Sleep 2006; 29: 1189–94.

Historical

PassouantP.The history of narcolepsy. In: GuilleminaultC, DementWC, PassouantP, eds. Narcolepsy. New York: Spectrum, 1976; 3–14.
WilsonS.The narcolepsies. Brain 1928; 51: 63–77.

Review

BaumannCR, BassettiCL.Hypocretins (orexins) and sleep-wake disorders. Lancet Neurol 2005; 4: 673–82.

General

AASM (American Academy of Sleep Medicine). International Classification of Sleep Disorders, 2nd edn.: Diagnostic and Coding Manual. Westchester, Illinois: American Academy of Sleep Medicine, 2005.
LittnerMR, KushidaC, WiseM, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005; 28: 113–21.
MignotE, LammersGJ, RipleyB, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002; 59: 1553–62.
MorgenthalerTI, KapurVK, BrownT, et al. Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep 2007; 30: 1705–11.
SilberMH, RyeDB.Solving the mystery of narcolepsy. The hypocretin story. Neurology 2001; 56: 1616–18.
WeaverTE, CuéllarN.A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy. Sleep 2006; 29: 1189–94.

Suggested reading

Historical
YossRE, DalyDD. Criteria for the diagnosis of the narcoleptic syndrome. Mayo Clin Proc 1957; 32: 320–8.
Review
BassettiCL.Narcolepsy. In: CulebrasA, ed. Sleep Disorders and Neurological Diseases, 2nd edn. New York: Informa Healthcare, 2007; 83–116.
General
AugerRR, GoodmanSH, SilberMH, et al. Risks of high dose stimulants in the treatment of disorders of excessive somnolence: a case–control study. Sleep 2005; 28: 667–72.
DouglassAB, HaysP, PazderkaF, RusselJM. Florid refractory schizophrenias that turn out to be treatable variants of HLA-associated narcolepsy. J Nerv Ment Dis 1991; 179: 12–17.
GuilleminaultC, PelayoR. Narcolepsy in prepubertal children. Ann Neurol 1998; 43: 135–42.
KondziellaD, Arlien-SoborgP. Diagnostic and therapeutic challenges in narcolepsy-related psychosis. J Clin Psychiatry 2006; 67: 1817–19.
KrahnLE, HansenMR, ShepardJW. Pseudocataplexy. Psychosomatics 2001; 42: 356–8.
ParkesJD, BaraitserM, MarsdenCD, AsselmanP. Natural history, symptoms and treatment of the narcoleptic syndrome. Acta Neurol Scand 1975; 52: 337–53.

Historical

YossRE, DalyDD. Criteria for the diagnosis of the narcoleptic syndrome. Mayo Clin Proc 1957; 32: 320–8.

Review

BassettiCL.Narcolepsy. In: CulebrasA, ed. Sleep Disorders and Neurological Diseases, 2nd edn. New York: Informa Healthcare, 2007; 83–116.

General

AugerRR, GoodmanSH, SilberMH, et al. Risks of high dose stimulants in the treatment of disorders of excessive somnolence: a case–control study. Sleep 2005; 28: 667–72.
DouglassAB, HaysP, PazderkaF, RusselJM. Florid refractory schizophrenias that turn out to be treatable variants of HLA-associated narcolepsy. J Nerv Ment Dis 1991; 179: 12–17.
GuilleminaultC, PelayoR. Narcolepsy in prepubertal children. Ann Neurol 1998; 43: 135–42.
KondziellaD, Arlien-SoborgP. Diagnostic and therapeutic challenges in narcolepsy-related psychosis. J Clin Psychiatry 2006; 67: 1817–19.
KrahnLE, HansenMR, ShepardJW. Pseudocataplexy. Psychosomatics 2001; 42: 356–8.
ParkesJD, BaraitserM, MarsdenCD, AsselmanP. Natural history, symptoms and treatment of the narcoleptic syndrome. Acta Neurol Scand 1975; 52: 337–53.